ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,161Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 68

$714K Total Retail Price of All Prescriptions

Rank: 10 out of 68

763 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 763 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

4% of this provider’s 763 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 8,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 395 375 1 2
ATORVASTATIN CALCIUM 392 366 2 13
LISINOPRIL 375 343 3 4
OMEPRAZOLE 327 274 4 5
METOPROLOL TARTRATE 248 239 5 6
SIMVASTATIN 231 223 6 1
PRAVASTATIN SODIUM 195 185 7 29
AMLODIPINE BESYLATE 184 169 8 7
HYDROCHLOROTHIAZIDE 180 180 9 11
FUROSEMIDE 179 159 10 3
PANTOPRAZOLE SODIUM 174 163 11 30
WARFARIN SODIUM 155 148 12 8
DIOVAN 143 142 13 42
METFORMIN HCL 141 126 14 14
ALENDRONATE SODIUM 135 134 15 26
GABAPENTIN 127 121 16 12
ATENOLOL 111 111 17 21
SYNTHROID 102 101 18 102
POTASSIUM CHLORIDE 101 95 19 18
GLYBURIDE 98 98 R 20 65
DONEPEZIL HCL 95 95 21 10
CARVEDILOL 94 80 22 27
TRAMADOL HCL 92 85 23 23
SPIRIVA 87 86 24 60
MIRTAZAPINE 86 86 25 15
ESCITALOPRAM OXALATE 85 76 26 38
ADVAIR DISKUS 85 72 26 41
NAMENDA 84 84 28 16
PRADAXA 84 82 28 198
HYDROCODONE-ACETAMINOPHEN 84 66 S3 28 17
NEXIUM 84 79 28 62
CITALOPRAM HBR 82 69 32 9
GLIMEPIRIDE 76 69 33 69
LOSARTAN POTASSIUM 72 67 34 37
TRIAMTERENE-HCTZ 72 69 34 67
FINASTERIDE 71 67 36 70
EXELON 69 69 37 57
AZITHROMYCIN 68 58 38 97
KLOR-CON M20 66 63 39 40
CLOPIDOGREL 62 58 40 31
CELEBREX 55 51 41 112
IRBESARTAN 54 54 42 279
PAROXETINE HCL 53 48 43 93
PRANDIN 52 50 44 107
PREDNISONE 51 51 45 47
QUINAPRIL HCL 50 46 46 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.